Mar 20 |
Scholar Rock Holding Corp Reports Full Year 2023 Financial Results
|
Mar 19 |
Scholar Rock GAAP EPS of -$1.99 in-line
|
Mar 19 |
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
|
Mar 15 |
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 15 |
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
|
Feb 15 |
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
|
Feb 6 |
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
|
Jan 25 |
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
|
Jan 23 |
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
|
Jan 22 |
Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That
|